Patent · US Active

Enone reductases

US8329438B2 · kind B2 · utility

5Cited by

9References

14Claims

0Family size

Assignee

Codexis, Inc. · US

Inventors

Christopher Savile · Santa Clara, US
Vesna Mitchell · San Jose, US
Xiyun Zhang · Fremont, US
Gjalt W. Huisman · Redwood City, US

Key dates

Filing date	Dec 23, 2009
Grant date	Dec 11, 2012
Priority date	—
Expiry date	Nov 20, 2030

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/52
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The disclosure relates to engineered enone reductase polypeptides having improved properties, polynucleotides encoding the engineered polypeptides, related vectors, host cells, and methods for making the engineered enone reductase polypeptides. The disclosure also provides methods of using the engineered enone reductase polypeptides for chemical transformations.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.